LRRK2 and Parkinson disease: Thus, we propose that, depending on the mutation carried by the patients (i.e., LRRK2 or SNCA), and depending on the specific cell type, ITPKB may contribute to PD with different mechanisms involving calcium homeostasis, and thus act as a protective or risk factor.